Mergent

Emergent BioSolutions is a global life sciences company dedicated to providing preparedness and response solutions for public health threats, including biological warfare agents and emerging infectious diseases. The company is widely recognized for its biodefense portfolio, which includes the anthrax vaccine BioThrax and the smallpox vaccine ACAM2000, as well as its critical opioid overdose reversal agent, Narcan (naloxone HCl) nasal spray. Beyond its proprietary products, Emergent operates as a contract development and manufacturing organization (CDMO), offering specialized services for vaccines and therapeutics to government and commercial partners. Despite recent manufacturing and financial challenges, the company remains a vital partner for agencies like BARDA and the CDC in maintaining national stockpiles and addressing urgent public health crises.